Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
- 1 May 2007
- journal article
- review article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 21 (3) , 283-301
Abstract
N-methyL-D-aspartate (NMDA) receptor antagonists, such as ketamine and phencyclidine, induce perceptual abnormalities, psychosis-like symptoms, and mood changes in healthy humans and patients with schizophrenia. The similarity between NMDA receptor antagonist-induced psychosis and schizophrenia has led to the widespread use of the drugs to provide models to aid the development of novel treatments for the disorder. This review investigates the predictive validity of NMDA receptor antagonist models based on a range of novel treatments that have now reached clinical trials. Furthermore, it considers the extent to which the different hypotheses that have been proposed to account for the psychotomimetic effects of NMDA receptor antagonist have been validated by the results of these trials. Finally, the review discusses some of the caveats associated with use of the models and some suggestions as to how a greater use of translational markers might ensure progress in understanding the relationship between the models and schizophrenia.Keywords
This publication has 215 references indexed in Scilit:
- Prepulse inhibition is different in two inbred mouse strains (CPB-K and BALB/cJ) with different hippocampal NMDA receptor densitiesBehavioural Brain Research, 2006
- Dopamine agonist action of phencyclidineSynapse, 2005
- Genes, dopamine and cortical signal-to-noise ratio in schizophreniaTrends in Neurosciences, 2004
- Distribution of mGluR1α and mGluR5 immunolabeling in primate prefrontal cortexJournal of Comparative Neurology, 2003
- Relation between hippocampal γ waves and behavioral disturbances induced by phencyclidine and methamphetamineBehavioural Brain Research, 2000
- Emerging principles of altered neural circuitry in schizophreniaBrain Research Reviews, 2000
- The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in miceJournal of Neural Transmission, 1999
- Glycine and D-serine decrease MK-801-induced hyperactivity in miceJournal of Neural Transmission, 1997
- The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosisBehavioural Brain Research, 1996
- Phencyclidine and the midbrain dopamine system: Electrophysiology and behaviorNeurotoxicology and Teratology, 1994